insights_auto
Why is CSBR down 2,72%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,65 $
arrow_downward
-2,72%(-0,13) 1D
12 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,64 $
High
4,70 $
Low
4,60 $
Mkt. cap
64,72 մլն
Avg. vol.
8,11 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,59 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,64 $
High
4,70 $
Low
4,60 $
Mkt. cap
64,72 մլն
Avg. vol.
8,11 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,59 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
Trefis
·
1 ժամ առաջ
Nvidia Is 6.1% Of Your S&P 500 Fund. What Is Your Number?
Investing.com
·
1 ժամ առաջ
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Yahoo Finance
·
25 րոպե առաջ
The S&P 500 Recently Experienced Its Worst Day Since 2025. Here's Why Investors Shouldn't Worry.
FOREX.com
·
1 ժամ առաջ
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com